Teva Pharma (TEVA) Lowers Quarterly Dividend 75% to $0.085; 1.1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Teva Reports Second Quarter 2017 Financial Results
August 3, 2017 6:30 AM EDTRevenues of $5.7 billion
GAAP EPS loss of $5.94
Non-GAAP EPS of $1.02
2017 business outlook revised to non-GAAP EPS of $4.30 - $4.50
Teva announces second quarter 2017 dividend of 8.5 cents,
down
75% from 34 cents in the first quarter of 2017
JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended June 30, 2017.
Second quarter results were lower than we anticipated due to... More
